Cancer Research UK and Guardant Health have initiated a collaborative effort focused on advancing cancer research and clinical development activities.…
Browsing: Liquid Biopsy
A study on the cost-effectiveness of liquid biopsy compared to colonoscopy for colorectal cancer (CRC) screening. Here’s a summary of…
The “ColoSense” multitarget stool RNA test has demonstrated superior sensitivity and specificity for detecting colorectal cancer and advanced adenomas compared…
A recent study conducted by the Regenstrief Institute and led by Research Scientist Thomas F. Imperiale, M.D., suggests that a…
This research, published in Cell Reports Medicine, explores the potential of circulating cell-free RNA (cfRNA) in blood plasma as a…
Universal DX (UDX), a liquid biopsy firm, successfully closes a Series B financing round of approximately $70 million. Key highlights…
Biotech company AnchorDx has formed a long-term partnership with molecular diagnostics firm DiaCarta to develop and commercialize cancer diagnostic products…
Lucid Diagnostics, a medical diagnostics company specializing in cancer prevention, has announced the launch of the next generation of its…
A new blood test, named the Galleri liquid biopsy, has been introduced to the market, offering the potential to detect…
Motus GI Holdings, Inc., a medical technology company focused on enhancing endoscopic outcomes, has announced that it has secured clearance…